IMUGENE LIMITED — Director's Dealing 2018

Jul 11, 2018

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.	Introduced 30/9/2001.	Amended 01/01/11	Amended 01/01/11
	Name of Entity:		Imugene Limited (ASX:IMU)
	ACN:		009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Charles Walker
Date of Last Notice:	28 December 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

irector” should be disclosed in this part.
Direct or Indirect Interest Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Date of change No. of securities held prior to change Class Number acquired Number disposed		Direct 11 July 2018 Shares Direct 27,462,500 Indirect - Total 27,462,500 Ordinary Shares Shares		Options 325,000 - 325,000 Options 123,456 - 123,456 Options - - -
			Shares
		Direct	370,370 - 370,370
		Indirect
		Total
			Shares
		Direct	- - -
		Indirect
		Total

• See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		$10,000
No. of securities held after change				Options 448,456 - 448,456
			Shares	Options
		Direct	27,832,870	448,456
		Indirect	-	-
		**Total **	27,832,870	448,456
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back		Participation in entitlement offer (with free attaching options as detailed in the prospectus dated 7 June 2018).

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

irector” should be disclosed in this part.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 – Closed period

art 3 – Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

==> picture [39 x 24] intentionally omitted <==

The CFO Solution

12 July 2018

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011